Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and vendex

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with vendex in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(vendex)
Trials
(vendex)
Recent Studies (post-2010) (vendex)
9,15618755210,6981,2835,830

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonopoulou, S; Athanasopoulos, S; Fragopoulou, E; Milias, GA; Nomikos, T1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and vendex

ArticleYear
Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers.
    European journal of applied physiology, 2005, Volume: 95, Issue:5-6

    Topics: Adult; C-Reactive Protein; Complement C3; Creatine Kinase; Elbow Joint; Exercise; Fibrinogen; Humans; Inflammation; L-Lactate Dehydrogenase; Leukocyte Count; Male; Muscle Contraction; Muscle, Skeletal; Platelet Activating Factor; Torque

2005